67

Business

Novo Nordisk sued over anti-competitive practices

admin
January 17th, 2014


This article is more than 10 years old.

Drug distribution companies are suing for lost earnings after Novo Nordisk kept a cheaper generic version of its drug off the market

Pharmaceutical giant Novo Nordisk is being sued in the US by drug distribution companies that accuse Novo of anti-competitive practices, Jyllands-Posten newspaper reports.

Novo Nordisk is accused of keeping cheaper generic copies of its drug Prandin off the market, forcing drug distribution companies to pay for a more expensive product.

Sales of Prandin earn the Danish company around 1.4 billion kroner a year, but their monopoly ended in June when a court found that its competitor Caraco was entitled to sell a generic copy.

READ MORE: Novo struggling with illegal hormone sales

Protecting monopoly
Caraco applied to produce its generic version in 2005 in advance of Novo Nordisk’s patent expiring in 2009, but Novo Nordisk blocked it through legal action and by attempting to extend its patent by changing its description in the so-called ‘Orange Book’ of approved drugs in the US.

The June ruling means that consumers have been paying inflated prices for the drug, leading three distribution companies – American Sales Company, Rochester Drug Co-op and Cardinal – to sue for lost earnings.

The generic version of Prandin is now on the market, and the damages will be calculated based on the price of the drug if the generic version had entered the market when it should have.

READ MORE: Lundbeck fined 700mn kroner for blocking generic

Blocking competition
Jyllands-Posten reports that the parties tend to settle in these types of cases and the damages could reach several hundred million kroner, but Novo Nordisk has said it will try and get the case dismissed from court.

Novo Nordisk is not the only Danish pharmaceutical accused of anti-competitive practices.

In June the EU fined Lundbeck 700 million kroner for conspiring with competitors to delay the introduction of generic versions of its drugs into the market. 


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”